Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12319740 | Methods for production of tissue resident memory-like T cells and use thereof | Farah HASAN | 2025-06-03 |
| 12202877 | T cell receptors with mage-B2 specificity and uses thereof | Ke PAN | 2025-01-21 |
| 12178787 | T cell receptors for immunotherapy | Gregory Lizée | 2024-12-31 |
| 12173317 | Use of histone modifiers to reprogram effector T cells | Junmei Wang | 2024-12-24 |
| 11696933 | HLA-restricted VCX/Y peptides and T cell receptors and use thereof | Ke PAN | 2023-07-11 |
| 11684657 | HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject | Gregory Lizée, Janos ROSZIK | 2023-06-27 |
| 11306289 | Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens | — | 2022-04-19 |
| 11098284 | Enhanced generation of cytotoxic T-lymphocytes by IL-21 mediated FOXP3 suppression | Yongqing Li | 2021-08-24 |
| 11052140 | Methods of treatment using conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses | Yongqing Li, C. Siddiq Abdul-Alim | 2021-07-06 |
| 10328135 | Method of obtaining cytolytic T cells by using mutant tumor epitopes | Yongqing Li, C. Siddiq Abdul-Alim | 2019-06-25 |
| 10072246 | Enhanced generation of cytotoxic T lymphocytes by IL-21 mediated FoxP3 suppression | Yongqing Li | 2018-09-11 |
| 9951310 | Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens | — | 2018-04-24 |
| 9938498 | Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cells | Kyung Mi Lee, Seon Ah Lim | 2018-04-10 |
| 9809797 | Enhanced generation of cytotoxic T-lymphocytes by IL-21 mediated FOXP3 suppression | Yongqing Li | 2017-11-07 |
| 9314516 | Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses | Yongqing Li, C. Siddiq Abdul-Alim | 2016-04-19 |